Brief: Organon Q3 Adjusted EPS USD 0.87 Vs. IBES Estimate USD 0.9
31/10/2024 11:30
Oct 31 (Reuters) - Organon Q3 revenue USD 1,582 million vs. IBES estimate USD 1,561 million. * Q3 EPS USD 1.38 * Q3 net income USD 359 million * Q3 adjusted EBITDA USD 459 million * Q3 adjusted EBITDA margin 29% * Q3 adjusted net income USD 226 million vs. IBES estimate USD 226.4 million * Q3 gross margin 58.3% * outlook FY revenue USD 6,375-6,425 million
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary